Clinical Trials in Nashville

Showing 12401-12420 of 17,403 trials

A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)

NCT00726323

This clinical study is being conducted at multiple sites to determine the best confirmed response rate, safety, and tolerability of GSK1363089 treatment in papillary renal cell carcinoma. Papillary renal cell carcinoma may be classified into hereditary and sporadic forms; subjects with either classification will be accepted into this study.

Carcinoma, Renal Cell

GlaxoSmithKline74 participantsStarted Jun 2006

Greenbrae, California, United States • San Francisco, California, United States • Stanford, California, United States +9 more locations

COMPLETEDNA< 1 mile

Evaluation of the Ulthera System for the Treatment of the Decolletage

NCT01713686

This is prospective, multi-center clinical trial. Enrolled subjects will receive one Ulthera® treatment on the decolletage. Follow-up visits will occur at 90 and 180 days following treatment. Study images will be obtained pre-treatment, immediately post-treatment, and at each follow-up visit.

Chest Wrinkles

Ulthera, Inc129 participantsStarted Oct 2012

Sacramento, California, United States • San Diego, California, United States • Chicago, Illinois, United States +1 more locations

A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)

Evaluation of the Ulthera System for the Treatment of the Decolletage

Find Trials by Condition in Nashville

Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk

A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes

Safety and Efficacy Trial of Testosterone Undecanoate

Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older

Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers

A Study to Evaluate the Effect of Camicinal on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects With Gastroparesis

Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II

A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease

LifeVest Post-CABG Registry

Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer

Comparison of Cervical Laminectomy to Laminoplasty

Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)

Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use

An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort

Use of Infliximab for the Treatment of Pemphigus Vulgaris

Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma

Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects

Long-term Efficacy and Safety of Repeated Ofatumumab Treatment Courses in RA Patients Who Previously Received Ofatumumab or Placebo in Trial Hx-CD20-403